Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times  “The Vaccines We Have Are Good. But They Could Be So Much Better” [...]

Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19 From globenewswire.com: Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing [...]

Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman. From globenewswire.com: Voltron Therapeutics, Inc. today announced that it has appointed life science veteran Anthony [...]

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy” Featuring Michael V. Callahan, MD, MSPH, DTM&H (U.K), Massachusetts General Hospital (MGH) Infectious Disease and Director, [...]

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19 Animal Trials to Assess the Effect of Novel Vaccine HaloVax™ Against COVID-19 July 08, 2020 08:30 ET [...]

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary Unique, Self-Assembling Vaccine Against COVID-19 is in Animal Testing July 09, 2020 09:25 ET | Source: [...]